Indianapolis Today

By the People, for the People

Stock Picks

Recent news

Opes Wealth Management Trims Stake in Eli Lilly

Fund reduced holdings in pharmaceutical giant by nearly 73% in Q3

Captrust Financial Advisors Trims Stake in Eli Lilly and Company

Institutional investor reduces holdings in pharmaceutical giant by 1.7% in Q3

Eli Lilly Shares Bought by Mirabella Financial Services

Institutional investor increases stake in pharmaceutical giant

Dodge & Cox Sells 1,573 Shares of Eli Lilly and Company

Hedge fund reduces stake in pharmaceutical giant

Banque Transatlantique SA Reduces Stake in Eli Lilly and Company

Institutional investor cuts holdings in pharmaceutical giant by 8.2% in Q3

Bank of Hawaii Reduces Eli Lilly and Company Holdings by 21.5%

The bank's stock holdings in the pharmaceutical company decreased to $5.70 million in the third quarter.

FourThought Financial Partners Boosts Eli Lilly Stake

Institutional investor increased its position in pharmaceutical giant by 71.9% in Q3 2025

LGT Fund Management Co Ltd. Sells 6,686 Shares of Eli Lilly and Company

Institutional investor reduces stake in pharmaceutical giant

PFG Advisors Trims Stake in Eli Lilly and Company

Investment firm reduces holdings in pharmaceutical giant by over 73%

Matthew 25 Management Corp Boosts Eli Lilly Stake

Investment firm increases holding in pharmaceutical giant by 113.8%

Korea Investment CORP Increases Stake in Eli Lilly and Company

The investment firm now owns over $516 million in Eli Lilly shares.

Capasso Planning Partners Trims Stake in Eli Lilly

Institutional investor reduces holding in pharmaceutical giant by over 40%

Eli Lilly Shares Bought by Power Wealth Management

Institutional investor increases stake in pharmaceutical giant by 185.8% in Q3

River Wealth Advisors Reduces Elevance Health Stock Position

Investment firm cuts stake in health insurance provider by nearly 60% in Q3

Close Asset Management Ltd Trims Holdings in Eli Lilly and Company

The institutional investor reduced its stake in the pharmaceutical giant by 3.1% in the third quarter.